Silver Book Fact

Predicted incidence of VTE, 2050

The incidence of VTE is predicted to more than double by 2050—from 0.95 million in 2006 to 1.82 million in 2050.

Deitelzweig, S, BH Johnson, J Lin, and KL Schulman. Prevalence of Clinical Venous Thromboembolism in the USA: Current trends and future projections. Heamtol. 2010; DOI: 10.1002/ajh.21917. http://www.ncbi.nlm.nih.gov/pubmed/21264912

Reference

Title
Prevalence of Clinical Venous Thromboembolism in the USA: Current trends and future projections
Publication
Heamtol
Publication Date
2010
Authors
Deitelzweig, S, BH Johnson, J Lin, and KL Schulman
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Human Burden

Related Facts

  • All-cause mortality for aortic valve disorders
    In 2014, all-cause mortality for aortic valve disorders was 34,408 in the U.S.  
  • Around 81% of people who die from coronary heart disease are 65 years and older.  
  • Stroke accounts for 1 in every 18 deaths in the U.S.  
  • Hospital costs for ischemic stroke
    Hospital costs for nonrecurrent ischemic stroke are 20% higher in patients with atrial fibrillation, than in patients without the disease.  
  • The mean lifetime cost of ischemic stroke in the U.S. is an estimated $140,048. This cost includes inpatient care, rehabilitation, and follow-up care.